(GRPM) S&P MidCap 400 GARP - Overview
Etf: Mid-Cap, Growth, Quality, Value
Dividends
| Dividend Yield | 1.27% |
| Yield on Cost 5y | 1.78% |
| Yield CAGR 5y | 12.86% |
| Payout Consistency | 95.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.9% |
| Relative Tail Risk | -6.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | -5.60 |
| Character TTM | |
|---|---|
| Beta | 1.068 |
| Beta Downside | 1.061 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.09% |
| CAGR/Max DD | 0.43 |
Description: GRPM S&P MidCap 400 GARP December 28, 2025
The Invesco S&P MidCap 400 GARP ETF (GRPM) seeks to replicate the performance of the S&P MidCap 400 GARP Index, allocating at least 90% of its assets to the index’s constituents. The index selects the top 60 mid-cap growth stocks from the broader S&P MidCap 400, filtered for relatively high quality and value composite scores as defined by the index methodology.
Key metrics (as of Q3 2025): expense ratio ≈ 0.30%, assets under management ≈ $1.2 billion, and a 5-year annualized total return of roughly 9.8%, outpacing the broader S&P MidCap 400 (~7.5%). The fund’s sector tilt leans toward technology (≈ 35% of assets) and healthcare (≈ 22%), both of which benefit from ongoing US GDP growth and a low-interest-rate environment that supports earnings expansion for growth-oriented mid-caps.
For a deeper, data-driven analysis of GRPM’s valuation and risk profile, you may find ValueRay’s interactive dashboards useful.
What is the price of GRPM shares?
Over the past week, the price has changed by +2.57%, over one month by +1.30%, over three months by +6.59% and over the past year by +10.70%.
Is GRPM a buy, sell or hold?
What are the forecasts/targets for the GRPM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 137.7 | 10.4% |
GRPM Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 519.1m USD (519.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 519.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 519.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.85% (E(519.1m)/V(519.1m) * Re(9.85%) + (debt-free company))
Discount Rate = 9.85% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)